Occudo Quantitative Strategies’s Epizyme, Inc EPZM Stock Holding History

Occudo Quantitative Strategies’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-22,631	Closed	-$33K	–	1513
2022 Q2	$33K	Sell	22,631 -4,716	-17%	-$3.47K	﹤0.01%	1086
2022 Q1	$31K	Buy	27,347 +11,384	+71%	+$18.6K	﹤0.01%	1095
2021 Q4	$40K	Buy	+15,963	New	+$62.7K	﹤0.01%	1022

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Occudo Quantitative Strategies's EPZM Position: Q3 2022 in Review

Occudo Quantitative Strategies sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 22,631 shares — an estimated $33K sold.

Occudo Quantitative Strategies first reported a position in EPZM in Q4 2021 and held it in 3 quarters. The position peaked at $40K in Q4 2021. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Occudo Quantitative Strategies reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Occudo Quantitative Strategies sold 22,631 Epizyme, Inc shares in Q3 2022, an estimated $33K.
Occudo Quantitative Strategies first reported a position in Epizyme, Inc in Q4 2021 and held it in 3 quarters.
Occudo Quantitative Strategies's Epizyme, Inc position peaked at $40K in Q4 2021.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.